Interferon –alpha 2b (PDferon B®) in Treatment of HBeAgnegative Chronic Hepatitis B; Preliminary Report

Abstract

Aims: In this report we aim to assess therapeutic efficiency and safety of particular brand of IFN-alpha 2b (PDferon B®) in patients with HBeAg negative-CHB in Iran.  

Description

Keywords

Citation

URI

Endorsement

Review

Supplemented By

Referenced By